RG
Ramakrishna Guduru
About Ramakrishna Guduru
Data last updated:
Ramakrishna Guduru is a Director at Zasya Life Sciences Private Limited (since 2022) and Director at Neovant Therapeutics Private Limited (since 2023). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹12.03 Cr; the largest is Zasya Life Sciences Private Limited at ₹9.37 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 13 Jan 2022 | 2021 | ₹9.37 Cr (FY 2025) | Active | |
| Director | 10 Mar 2023 | 2023 | ₹2.66 Cr (FY 2025) | Active |
Board colleagues of Ramakrishna Guduru
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dilip Shankarbhai Chaudhary | 01354482 | Zasya Life Sciences Private Limited , Neovant Therapeutics Private Limited | Whole-Time Director |
| Nirav Pravinkumar Trivedi | 07305698 | Zasya Life Sciences Private Limited , Neovant Therapeutics Private Limited | Director |
| Ramaswamy Akula | 09322825 | Zasya Life Sciences Private Limited | Whole-Time Director |
| Siddhanand Narendranath Padukone | 09465128 | Zasya Life Sciences Private Limited | Director |
| Dashrathbhai Kalidas Patel | 00155539 | Neovant Therapeutics Private Limited | Director |
| Jagdish Madhavlal Chaudhary | 01687830 | Neovant Therapeutics Private Limited | Director |
| Patwa Anmol Ajaybhai | 06749808 | Neovant Therapeutics Private Limited | Director |
| Umesh Vinayakrao Barabde | 10347239 | Neovant Therapeutics Private Limited | Director |
| Vishakh Ramrao Kharat | 10367869 | Neovant Therapeutics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramakrishna Guduru
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramakrishna Guduru
Ramakrishna Guduru currently holds 2 directorships: Zasya Life Sciences Private Limited (Director, since 13 Jan 2022, revenue ₹9.37 Cr (FY 2025)); Neovant Therapeutics Private Limited (Director, since 10 Mar 2023, revenue ₹2.66 Cr (FY 2025)).
Ramakrishna Guduru was first appointed on 13 Jan 2022 as Director at Zasya Life Sciences Private Limited. The most recent appointment on record is 10 Mar 2023 at Neovant Therapeutics Private Limited.
The 2 current companies of Ramakrishna Guduru that report revenue have a combined latest revenue of ₹12.03 Cr: Zasya Life Sciences Private Limited ₹9.37 Cr (FY 2025); Neovant Therapeutics Private Limited ₹2.66 Cr (FY 2025).
The current boards of Ramakrishna Guduru's companies include Dilip Shankarbhai Chaudhary (Zasya Life Sciences Private Limited), Nirav Pravinkumar Trivedi (Zasya Life Sciences Private Limited), Ramaswamy Akula (Zasya Life Sciences Private Limited), Siddhanand Narendranath Padukone (Zasya Life Sciences Private Limited), Dashrathbhai Kalidas Patel (Neovant Therapeutics Private Limited), Jagdish Madhavlal Chaudhary (Neovant Therapeutics Private Limited), among others.